Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
EBITDA as a percentage of revenue
Latest
-600.95%
↑ 70% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-2032.63%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -600.95% | +24.4% |
| 2024 | -794.57% | +45.0% |
| 2023 | -1445.07% | -120.8% |
| 2022 | -654.58% | -33.6% |
| 2021 | -489.99% | +80.3% |
| 2020 | -2483.48% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | +100.0% |
| 2017 | -8680.00% | -67.6% |
| 2016 | -5177.69% | - |